In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

Martin A. Makary, MD, of Johns Hopkins University, a critic of vaccination schedules and COVID-19 measures promulgated by ...

BridgeBio received FDA approval for Attruby (acoramidis), a near complete TTR stabilizer (≥90%), approved to reduce ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

Lipid nanoparticles made from lipids optimized via directed chemical evolution show high performance as mRNA delivery vehicles.

A new approach for identifying new cellular RNA targets of snoRNAs uncovered thousands of previously unknown targets ...

Researchers have mapped the activity of repair proteins in individual human cells. The study demonstrates how these proteins ...

Research indicates that dilated cardiomyopathy can be caused by the cumulative influence of potentially thousands of genes, not just one single genetic variant.

Researchers have taken inspiration from jet propulsion mechanisms of cephalopods to develop an innovative ingestible capsule.